Dioxin exposure and porcine reproductive hormonal activity

To characterize the action of 2,3,7,8-tetrachlorodibenzo-p-dioxin ( TCDD) during both the follicular and luteal phases of the ovarian cycle, the direct effect of TCDD was investigated in vitro using a system of primary monolayer cell culture. Granulosa and theca cells were collected from the preovulatory follicles and cultured as a co-culture, thus resembling follicles in vivo. Luteal cells were isolated from the corpora lutea collected during the midluteal phase. In both cases cells were isolated from the ovaries of animals exhibiting natural estrus cycle. Results of these experiments suggest that TCDD decreases estradiol secretion by follicular cells and progesterone secretion by luteal cells in a dose-dependent manner. It was also shown that TCDD disrupts steroidogenesis through its influence on the activity of enzymes involved in the steroid biosynthesis cascade. In luteal cells, its action is mediated via the aryl hydrocarbon receptor (AhR) and is probably independent of estrogen receptor (ER) stimulation. Endocrine disruptors that interfere with estradiol production in the follicles can act as ovulatory disruptors, and while interfering with progesterone production by luteal cells they can act as abortifacients.


ARTIGO ARTICLE
Dioxin exposure and porcine reproductive hormonal activity

Introduction
Extensive research over the past decade has identified a rapidly growing list of environmental contaminants that disrupt reproductive processes in vertebrates primarily by exerting estrogenic or antiestrogenic actions (Jobling et al., 1995;McLachlan, 1993).Most of these estrogenic xenobiotics are considered to exert their estrogenic effects primarily by binding to nuclear estrogen receptors (Gray et al., 1996;Tomas & Khan, 1997).Endocrine disruptors include industrial chemicals like pesticides, polychlorinated biphenyls (PCBs), dioxin, and other synthetic chemicals.Organochlorine industrial chemicals have been extensively used in the production of plastics, flame retardants, pesticides, drugs, and a host of other commercial products.The most biologically active congener is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Figure 1), for which the largest data base exists.TCDD is on the General Accounting Office (GAO) list of 20 reproductive and developmental toxicants, and the effects of chronic exposure to TCDD on reproduction in rodents have been well documented.
TCDD and related compounds elicit a diverse spectrum of toxic responses.Concern has increased that widespread adverse effects are occurring in humans, domestic animals, and wildlife populations as a result of exposure to environmental chemicals that possess endocrine-disrupting activity (Colborn et al., 1993(Colborn et al., , 1996)).
From animal studies, TCDD was postulated to exhibit a very wide organotropy, including skin, liver, endocrine organs, and the immune system, in addition to effects on reproduction and development and increased tumor incidence.The biological and toxic effects of TCDD have been studied extensively for more than 20 years.Growing evidence suggests that the re-productive system is one of the most sensitive targets for the adverse effects of these compounds (Gray Jr. & Osbtby, 1995;Safe, 1999).TCDD caused suppression of the estrous cycle, including decrease in the number and size of corpora lutea, decreased plasma progesterone concentrations, and aberrant ovarian stroma cells ( Johnson et al., 1976).Some effects of TCDD are modified by several other factors, especially female sex hormones.TCDD and other congeners are almost unique examples of environmental substances exhibiting receptor-mediated biological action and possible receptormediated toxicity (Poland & Knutson, 1982;Whitlock, 1993).
Endocrine glands secrete hormones, which act as chemical "messengers" within the body.By binding to receptors in cells they trigger very specific responses in these cells.
One way endocrine disruptors interfere with the role of natural hormones is by binding to hormone receptors.Some of them "mimic" the natural hormone, producing an identical cellular response.Even without receptor binding, endocrine disruptors may interfere with the synthesis, secretion, elimination, or action of natural hormones.Therefore, they may interfere with androgenic (male) and estrogenic (female) effects.
As deduced from animal studies, the overall biological and toxic actions of dioxins are rather complex, and they are not confined to one organ system.It is not always possible to directly and quantitatively predict the occurrence of substance-induced effects from animal data.Dose-response studies for such effects across species, tissues, and age brackets are quite limited.In our previous paper (Grochowalski et al., 2000), it has been shown that TCDD added to the culture media accumulates in the tissue and influences cell proliferation and steroid secretion.
In vitro systems are uniquely suited to investigate specific cellular and molecular mechanisms in the ovary and thus improve risk assessment.Original toxicants or their precursors or selective inhibitors can be individually added to isolated cell types to evaluate specific toxicity mechanisms.Numerous in vitro model systems are described in the literature.Most of the authors used luteinized granulosa cells collected from superovulated rats or women undergoing in vitro fertilization; therefore neither approach used physiological conditions.Enan et al. (1996) showed a decrease in progesterone production by luteinized granulosa cells after 24h exposure to 10nM of TCDD.In a study by Moran et al. (1997), TCDD was shown to reduce estradiol production by luteinized granulosa cells without any effect on progesterone production.In our laboratory, to study the direct effect of TCDD on ovarian steroidogenesis, we collected follicular and luteal cells from the porcine ovary excised from animals undergoing a natural estrous cycle.
Using this in vitro model, in our previous paper we suggested time-and cell-specific action of TCDD on ovarian steroidogenesis (Pieklo et al., 2000).This review will describe the direct, dose-dependent action of TCDD on follicular and luteal cell steroidogenesis, the influence of TCDD on specific enzymatic steps in the biosynthetic pathway of steroidogenesis, and involvement of the aryl hydrocarbon receptor (AhR) or estradiol receptor (ER) in this process.

Porcine ovarian function
The estrous cycle in the pig lasts from 18 to 22 days.Phase 1 starts at ovulation and extends through day 8.During this period growth of numerous follicles is initiated.Phase 2 lasts from day 9 to day 22 and can be divided into two periods: from day 9 to day 14, representing the period of maximal luteal activity, and from day 15, when the onset of luteal involution and follicular growth is accelerated (Stabenfeldt et al., 1969).The adult female ovary is a mass of follicles, corpora lutea, blood vessels, nerves, and connective tissue elements, all of which form a relatively heterogeneous array of histological units.
The number and size of the follicles vary depending on the reproductive state of the female.
In the pig, selection of ovulatory follicles is initiated between days 14 and 16 of the estrous cycle (Clark et al., 1982;Foxtroft & Hunter, 1985).The ovary performs two important roles, development and delivery of the female gamete (oocyte) and production of ovarian hormones, such as female sex steroids, estrogens, and progesterone.At the end of the follicular phase of the estrous cycle the Graafian follicles that reach maturity release their ova into the peritoneal cavity.
Reproductive toxicants can affect ovarian function in a variety of ways.First, indirectly by altering the pituitary output of gonadotropins (follicle-stimulating hormone -FSH -and luteinizing hormone -LH) (Figure 2).Alternatively, reproductive toxicants can have direct effects on ovarian steroid hormone production.
The ability to synthesize estradiol is an essential characteristic of the healthy ovarian follicles.
Estradiol is synthesized in granulosa cells from theca androgens.However, porcine theca cells have active aromatase and also can aromatize testosterone to estradiol.
Steroidogenesis begins by the conversion of cholesterol to pregnenolone by the side-chain cleavage accomplished by cytochrome P450 scc .This enzymatic step is characteristic of the steroidogenic cells of endocrine glands, including the testes, ovaries, and adrenal glands.However, the rate of steroid formation depends on the rate of cholesterol transport from intracellular stores to the inner mitochondrial membrane and loading of P450 scc with cholesterol.each experiment six ovaries from three animals were selected for cell preparation.Large follicles were obtained from ovaries and granulosa cells (Gc) and theca interna layers (Tc) were subsequently prepared.In co-culture experiments resembling in vivo follicles, granulosa and theca cells were inoculated at a concentration of 6.8x10 6 and 2.1x10 6 cells/ml respectively, at the concentration comparable to that observed in vivo (Gc:Tc = 3:1).Cells were cultured in Parker Medium (M199) supplemented with 10% calf serum with or without TCDD.The cultures were maintained at 37 o C in a humidified atmosphere of 5% CO 2 (Figure 3).In order to show dose-dependent TCDD action on estradiol secretion, doses of 0.1nM, 1.0nM, 10nM, and 100nM TCDD were added to the culture media.Cells were cultured for 48 hours, and then media were collected for estradiol estimation by radioimmunoassay using Spectria RIA kits (Orion, Diagnostica, Finland), supplied by Polatom (OEwierk, Poland).

Effects on follicular cell function
Effect of TCDD on cholesterol side chain cleavage cytochrome P450scc, 3β-hydroxysteroid dehydrogenase (3β-HSD), and cytochrome P450arom activities in follicular cells Granulosa and theca cells were plated together into 24 well plates for 18h incubation with M199 supplemented with 5% calf serum.Then, 25-hydroxycholesterol (25-OH) substrate for pregnenolone formation at a dose of 10µg/ml or pregnenolone (P5) substrate for progesterone production at a dose of 10µg/ml was added to the non-TCDD-treated control and TCDDtreated cells.Six hours later, all cultures were terminated and the media were frozen pending further progesterone, testosterone, and estradiol concentration analysis.Results of these experiments are shown in Figure 4.
It was stated that TCDD did not inhibit progesterone secretion by GT cells when the culture was supported by exogenous 25-OH cholesterol (a substrate for pregnenolone formation) and pregnenolone (a substrate for progesterone production).
These results suggest that this inhibition of progesterone is due to reduction in the activity of the mitochondrial enzyme, which converts cholesterol into pregnenolone (cytochrome P450 scc ) or pregnenolone to progesterone.The hypothesis drawn from this observation is that TCDD acts before pregnenolone formation.Moore et al. (1991) also noted that pregnenolone formation was blocked after treating rats with aminoglutethimide (AMG), the inhibitor of P450 scc .Previous studies provided evidence that the reduction in progesterone secretion must be due to the inhibition of mobilization of cholesterol to cytochrome P450 scc (DiBartolomeis et al., 1987).Moore et al. (1991) showed that testosterone synthesis was decreased in TCDD-treated rats because pregnenolone production by the testes was inhibited.This inhibition could only be caused by a reduction in the activity of the mitochondrial enzyme, which converts cholesterol into pregnenolone (cytochrome P450 scc ).A study conducted on female Cynomolgus monkeys given gavage doses of hexachlorobenzene (a highly lipophilic compound) reported decreases in serum P4 during the luteal phase (Foster et al., 1992).This agrees with data from Kleeman et al. (1990) obtained on male rats.They noted that TCDD did not decrease T secretion when steroidogenesis was supported by exogenous pregnenolone; thus, inhibition of T biosynthesis must result from an inhibition of pregnenolone formation.On the other hand, in 25-OH-and P5-supplemented cultures, TCDD decreased testosterone and estradiol secretion, indicating another mechanism involved in TCDD antiestrogenic action.Effect of TCDD on cytochrome P450arom activity in follicular cells P450 arom activity was measured by conversion of testosterone (10 -7 M) to estradiol.The net synthesis and secretion of estradiol to the culture medium was used as the indicator of the aromatase activity.Aromatase inhibitor (CGS 16949A; 4,5,6,7,8-tetrahydroimidazo [1,4-alpydrin-5-yl] benzonitrile monohydrochloride) at a dose of 0.1mM was used to confirm the action of TCDD on these enzymes.At the end the culture media were frozen for testosterone and estradiol analysis.Results are shown in Figure 5.
In this experiment we observed TCDD antiestrogenic action on GT co-cultured with testosterone, indicating that as in the case of P450 scc , TCDD also disrupted P450 arom .We observed that TCDD added to the testosteronesupplemented cultures additionally increased testosterone secretion with a concomitant decrease in estradiol secretion.Moreover, CGS 16949A the inhibitor of P450 arom added to TCDD-treated cells improved testosterone secretion to 146.8% of control cultures and additionally decreased estradiol secretion to 12.6% of TCDD-treated cells.This is in accordance with Dasmahapatra et al. (2000), who showed significant changes in P450 scc and P450 arom mRNA levels in rat granulosa cells under the influence of TCDD.

Effects on luteal cell function
After ovulation, follicular cells turn into luteal cells, which form the corpus luteum.Both granulosa and theca cells are involved in the formation of luteal tissue.The results of our earlier study (Gregoraszczuk, 1983) indicated that cells isolated from the corpus luteum formed in vivo are not identical to granulosa cells luteinized in vitro.Moreover, the corpus luteum is the ovarian compartment with a strictly limited life span.The regular cycle is dependent on the precise regulation of the life span of the corpus luteum.One of the endocrine functions of corpora lutea is the production of progesterone (Figure 6).
Progesterone synthesis is a complex steroidogenic pathway in the ovary.After ovulation, differentiation of follicular cells into luteal cells capable of producing progesterone is accomplished by increased expression of enzymes necessary for the conversion of cholesterol to progesterone, i.e., cholesterol side-chain cleavage cytochrome P450 scc and 3β-hydroxysteroid dehydrogenase (3β-HSD), and decreased expression of enzymes that convert progesterone to estrogens, i.e., 17 α-hydroxylase cytochrome P450 and aromatase cytochrome P450 (Figure 7).

Dose response curve
In order to show the dose response to TCDD in terms of progesterone secretion, luteal cells were cultured at four different doses: 0.1, 1.0, 10.0, and 100nM of TCDD.The cells were cultured for 48h and the media were evaluated for progesterone concentration (Figure 8).

Effect of TCDD on cholesterol side chain cleavage cytochrome P450scc or 3β-hydroxysteroid dehydrogenase (3β-HSD), enzymes involved in progesterone secretion
Cells were plated into 24 well plates for 18h incubation with M199 supplemented with 5% calf serum, after which 25-hydroxycholesterol (25-OH), substrate for pregnenolone formation at a dose 10µg/ml, or pregnenolone (P5), substrate for progesterone production at 10µg/ml, was added to the non-TCDD-treated control and TCDD-treated cells.Six hours later, all cultures were terminated and the media were frozen until further progesterone analysis.Results are shown in Figure 9.This study demonstrated that the exposure of luteal cells to 3.2ng/ml of TCDD in vitro caused a significant reduction of basal, 25-OHstimulated, and pregnenolone (P5)-stimulated progesterone secretion by luteal cells.
It also provided evidence that at least one of the effects of TCDD in reducing progesterone secretion was very likely through a direct action on the activity of the enzymes, which convert cholesterol to pregnenolone and pregnenolone The influence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on testosterone (T) and estradiol (E2) secretion.C = control culture; CGS = CGS 16949A inhibitor of aromatase activity.to progesterone.Luteal cytochrome P450 scc activity (assayed with 25-OH as a substrate) was decreased to 50% of control progesterone, while 3β-HSD activity (assayed with P5 as a substrate) was decreased to 70% of control progesterone.It provides evidence that the key lesion occurs prior to or during pregnenolone formation.Inhibition of histochemically tested activity of 3β-HSD was shown in our previous paper (Gregoraszczuk et al., 1999).
The involvement of aryl hydrocarbon receptor (AhR) and estradiol receptor (ER) in TCDD action on follicular and luteal cells The best characterized mechanism for the action of TCDD involves the cloned AhR (Burbach et al., 1992), a cytosolic receptor that binds TCDD and other halogenated aryl hydrocarbons.The complex heterodimerizes with the aryl hydrocarbon nuclear translocator (ARNT) and is translocated to the nucleus where it binds to several discrete DNA domains containing dioxin-responsive elements (DRE) (Carrier et al., 1994).The complex acts as a transcription factor to regulate the expression of genes such as CYP1A1, CYP1A2, and CYP1B1, which play important roles in estrogen metabolism (Zhu & Conney, 1998).Some authors suggest that AhR is not an essential regulator of the reproductive function (Schmidt et al., 1996), while others report that AhR may play a role in fertility and fecundity (Nerbert et al., 1984).Studies using AhR blockers are currently being conducted to examine the potential involvement of the AhR in TCDD action.Enan et al. (1996) showed that the reduction of glucose uptake by human luteinizing granulosa cells is mediated through AhR.Such an effect of TCDD was antagonized by the AhR blocker, α-naphthoflavone (ANF).
The presence of a functional AhR capable of binding DNA in the rat ovary and in primate ovarian tissue, including human granulosa cells, was shown by Chaffin et al. (1996Chaffin et al. ( , 1997)).Safe (1998) showed that toxic and biochemical effects associated with exposure to TCDD are mediated via its initial binding to the cytosol aryl hydrocarbon (Ah) receptor protein present in target tissues and organs.Levels of AhR appear to be the lowest in early CL, and increase in the mid-and late luteal phase tissues.Studies using the AhR blocker α-naphthoflavone are currently being conducted to examine the potential involvement of the AhR in TCDD action (Gasiewicz & Ahon, 1992).Caruso et al. (1999) investigated the 90kDaheat shock protein (HSP90) as a mediator of   cross-talk between the AhR and the ER signal transduction pathways in human breast cancer cells and demonstrated that Ah-responsiveness is dependent on cellular ER content.Some authors suggest that the TCDD receptor may be related to the estrogen receptor and that the antiestrogenic action of TCDD is probably independent of the Ah locus (Gallo et al., 1986).Tian et al. (1998) showed that TCDD suppresses the gene expression of the ER receptor by decreasing its transcription and that the AhR plays an important role in mediating this response.Kharat & Saatcioglu (1996) hypothesized that activated AhR competes with ER for some limiting transcription factor(s).On the other hand, DeVito et al. (1992) demonstrated that TCDD does not bind competitively to the E2 receptor, nor does E2 compete for the AhR.
Taking into consideration data by Umbreit & Gallo (1988) suggesting that TCDD's effects on reproductive functions may occur via modulating estradiol and/or ER depending on the species, tissue and hormonal status of an animal, 4-0H-tamoxifen (TMX), a synthetic ER antagonist that inhibits transcription of target gene binding to ER was used to focus on the effect of TCDD on ER.
Co-culture of granulosa and theca cells isolated from large preovulatory follicles and luteal cells were cultured in M199 medium supplemented with 5% calf serum as a control medium or with the addition of either TCDD (3.2ng/ml), α-naphthoflavone, the AhR inhibitor (10mM or TCDD + AhR-Inh), or 4-0Htamoxifen (4-OH-TMX), the inhibitor of ER (10 -7 M).Results for estradiol and progesterone secretion are shown in Figures 10 and 11.
These results demonstrate that the exposure of follicular cells to both the AhR blocker α-naphthoflavone and the ER blocker 4-OHtamoxifen reversed the inhibitory effect of TCDD on estradiol secretion, indicating possible involvement of a AhR-and ER-mediated mechanism in this process.However, exposure of luteal cells to the AhR blocker α-naphthoflavone reversed the inhibitory effect of TCDD on progesterone secretion, while 4-OHtamoxifen did not reverse the effect of TCDD, indicating the involvement of a AhR-mediated mechanism and non-ER-dependent signaling in TCDD action on luteal cells.This was probably due to low expression of ER in luteal cells.

Conclusions
• In the follicles, TCDD decreases estradiol secretion by follicular cells in a dose-dependent   manner by altering conversion of cholesterol to pregnenolone and testosterone to estradiol.Development and maturation of the oocyte occurs within ovarian follicles, therefore TCDD interfering with estradiol production in follicles can affect oocyte development and ovulation.• In the corpus luteum, TCDD decreases progesterone secretion in a dose-dependent manner by the reduction in the activity of mitochondrial enzymes, which convert cholesterol into pregnenolone.Therefore, by interfering with progesterone production it can act as an abortifacient.
• We suggest that there is cross-talk between the AhR and the ER signal transduction pathways in porcine follicular cells.In luteal cells, TCDD activity appears to be mediated via binding to the Ah receptors, probably independent of the ER locus.
Figure 1General structure of dioxins.
Figure 2The two-gonadotropin/two-cell concept of follicular estradiol production.

F
Figure 6Schematic representation of corpus luteum formation.
Figure 7Pathway for progesterone biosynthesis in luteal cells.

Figure 10 Influence
Figure 10 Influence of the AhR inhibitor (AhR-INH) a-naphthoflavone and the ER inhibitor 4-OH tamoxifen (TMX) on estradiol secretion by TCDD-treated co-culture of theca and granulosa cells (GT).

Figure 11 Influence
Figure 11 Influence of the AhR inhibitor (AhR-INH) a-naphthoflavone and the ER inhibitor 4-OH tamoxifen (TMX) on progesterone secretion by TCDD-treated luteal cells.